65 Therapeutics
Somerville, US · Founded 2024 · Delaware corporation
Founders & leadership
JK
Julius KnowlesNamed on SEC filing
Board
MC
Murthy ChavaliBoard director
Reported raises · per SEC filings
Form D private placements$6.7M disclosed across 1 round · 2024
▶$6.7MraisedJul 2026 · 2 investors · PharmaceuticalsRule 506(b)
▶$6.7MraisedJul 2026 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Julius KnowlesExecutive Officer, Director
- Murthy ChavaliDirector
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has 65 Therapeutics raised?
- 65 Therapeutics has disclosed $6.7M raised across 1 round.
- Where is 65 Therapeutics headquartered?
- 65 Therapeutics is headquartered in Somerville, US.